More on SGEN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings
- Holders
- FDA

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (5/1/15 *Est.)
- PDUFA (8/18/2015)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

SGEN Balance Sheet

Click line-items for a historical chart and %
Assets
Cash and cash equivalents 62.57M
Short-term investments
Interest receivable
Accounts receivable 49.59M
Prepaid expenses and other current assets 8.25M
Total current assets 396.92M
Property and equipment, net 44.92M
Long-term investments
Other non-current assets
Total assets 446.47M
Liabilities and Stockholders' Equity
Accounts payable and accrued liabilities
Current portion of deferred revenue 47.7M
Total current liabilities 128.15M
Long-term liabilities
Deferred revenue, less current portion 104.64M
Deferred rent and other long-term liabilities 4.4M
Total long-term liabilities 109.03M
Commitments and contingencies 0
Stockholders' equity
Preferred stock, $0.001 par value, 5,000 shares authorized; none issued and outstanding 0
Common stock, $0.001 par value, 250,000 shares authorized at June 30, 2011 and 150,000 shares authorized at December 31, 2010; 114,419 shares issued and outstanding at June 30, 2011 and 101,607 shares issued and outstanding at December 31, 2010 125K
Additional paid-in capital 1.04B
Accumulated other comprehensive loss -11K
Accumulated deficit -828.13M
Total stockholders' equity 209.29M
Total liabilities and stockholders' equity 446.47M